Navigation Links
ExcitePCR Announces its FireflyDX-Portable: A Lightweight, Bookbag-sized Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
Date:8/30/2017

ExcitePCR™ today announced the FireflyDX-Portable™, a rechargeable bookbag-sized realtime pathogen detection system that will enable first responders, medical professionals and food safety officials to accurately obtain on-site results anywhere in the world in less than 30 minutes … including sample preparation time.

The FireflyDX-Portable is designed for use in several multi-billion-dollar industries, markets where molecular diagnostics are critical to ensure rapid safety and treatment protocols. Unfortunately, today’s existing solutions for accurately identifying potential pathogens and bio-threats, especially at the Point-of-Care / Point-of-Need (POC / PON), can sometimes take as long as several hours to several days to provide results, dramatically delaying what is often life-saving treatment, while also increasing costs, both personal and financial. In addition, most state-of-the-art Polymerase Chain Reaction (PCR) solutions in use today for pathogen detection typically require a professionally trained operator working in a pristine laboratory setting and/or are heavy, bulky and tied to a personal computer to function properly.

By contrast, ExcitePCR’s FireflyDX-Portable is a standalone, bookbag-sized bio-threat detection system that can be operated by virtually anyone with minimal training yet still produces highly accurate results. In addition, the FireflyDX-Portable will deliver such results in under 30 minutes, including sample preparation (which generally takes the most time in pathogen detection).

“Recent market developments have inspired us to expand our development efforts onto a new path, one that will require little if any regulatory oversight initially, yet will allow us to solve the challenges faced by several markets,” said Lyle Probst, President, CEO and founder of ExcitePCR. “That’s why we’re announcing the FireflyDX-Portable system today, a bookbag-sized biohazard detection solution that can be used anywhere around the world and deliver extremely accurate results in minutes. In addition, we want our clients and potential partners to understand that we are continuing forward with our development work on a truly handheld pathogen detection system, which we now call the FireflyDX-Handheld™, a system we plan to have commercially available in 2019.”

THE FireflyDX™ FAMILY OF REALTIME PATHOGEN DETECTION SYSTEMS

Since 2013, ExcitePCR’s team has been developing a new type of biological detection system, one that is lightweight and rechargeable and
1.    Can be used in the field by non-professionals and non-technicians,
2.    Dramatically reduces sample prep time to as little as 10 minutes,
3.    Maintains the highest levels of accuracy found in lab-based PCR-based solutions,
4.    Does not require the use of a separate personal computing device,
5.    Can test for the presence of multiple pathogens simultaneously, and
6.    Provides highly accurate results in under 30 minutes (including sample preparation times).

Some of the milestones achieved by ExcitePCR on/with its FireflyDX technologies during the past four years include

  •     2014 co-awardee for the SenseNet I Program from the U.S. Department of the Interior on behalf of the U.S. Department of Homeland Security Science & Technology Directorate
  •     Signed a U.S. Special Operations Command (USSOCOM) agreement with Special Operations Research, Development, & Acquisition Center, Science & Technology Directorate (USSOCOM SORDAC-ST) in 2014
  •     Completed breadboard* design of the FireflyDX system and began in-lab testing
  •     Completed development of single-use, disposable cartridges with pre-programed RFID chips, with no end-user programing or setup required
  •     Successfully identified multiple organisms simultaneously on a FireflyDX breadboard in ExcitePCR’s laboratories
  •     Used a FireflyDX breadboard to successfully identify numerous organisms at the molecular level, including such targets as

o    Anthrax,
o    C. diff (Clostridium difficile), both Toxin A and B variants,
o    Ebola virus,
o    Genetically Modified food items (aka, GMOs),
o    Influenza (multiple strains),
o    MRSA (Methicillin-resistant Staphylococcus aureus),
o    MSSA (Methicillin-susceptible Staphylococcus aureus), and
o    Zika virus, among others.

ExcitePCR will release additional details about the FireflyDX-Portable and its FireflyDX advancements in the near future.

ABOUT ExcitePCR

ExcitePCR Corporation is developing portable realtime pathogen detection systems based upon superior sample preparation and realtime PCR (Polymerase Chain Reaction) methodologies. Its FireflyDX technologies will deliver rapid automated Point-of-Need / Point-of-Care (PON / POC) sample preparation and highly accurate biohazard identification in a fraction of the time currently possible using existing PCR-based solutions.

ExcitePCR, FireflyDX, FireflyDX-Portable and FireflyDX-Handheld are each trademarks of ExcitePCR Corporation. All other trademarks are the property of their respective owners.

  • — Breadboard = A reusable, solderless electronic circuit board prototype.

CONTACT: David Politis, dpolitis(at)excitepcr(dot)com, C: 801-556-8184

Read the full story at http://www.prweb.com/releases/ExcitePCR-Announces-the/FireflyDX-Portable/prweb14646542.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. ExcitePCR Releases its Company Facts Sheet
2. Thirty-Year Marketing Veteran, David L. Politis, Joins ExcitePCR as its Chief Marketing & Sales Officer
3. American Farmer Announces Episode, Featuring Federal Hybrids, Inc.
4. BioLife Solutions Announces Second Quarter 2017 Financial Results
5. HumanZyme® Announces Human Cell-Expressed Interferon beta for Immunology and Immunotherapy Research Applications
6. Cynvenio Announces New LiquidBiopsy Test for PD-L1 Expression in Lung Cancer
7. Tosoh Bioscience LLC Announces Partnership with PolyAnalytik Inc.
8. The Leader in Visual Electrophysiology Announces New Chief Medical Officer
9. Brain Sentinel Announces Business Partnership with Academy Medical to Bring Breakthrough SPEAC® System Seizure Monitor to Active and Retired Military with Epilepsy
10. Cynvenio Announces New Deployment of LiquidBiopsy® System at Leading Cancer Research Center in South Korea
11. NLP Logix Announces Joint Product Development Agreement with Mayo Clinic using Deep Learning and Deployment onto Microsoft Azure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2020)... ... July 30, 2020 , ... ... for the life sciences industry, today announced the release of its signature ... for Medical Science Liaisons (MSLs) and other field medical professionals. , ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign , ... and prevention of high-burden diseases, and Centric Consulting, a business and technology consulting ... utilize existing data in order to identify and prioritize patients for care. , ...
(Date:7/10/2020)... ... 2020 , ... In most research using the zebrafish model, ... in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the past ... the zebrafish model to investigate the causes of leukaemia and its relationship with ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
Breaking Biology Technology:
(Date:8/12/2020)... , ... August 12, 2020 , ... ... monitoring systems that are ideal for public health agencies of all sizes. With ... diseases and helping at-risk individuals find appropriate health care, Mosio helps public health ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • ... comparability study, but what is the most effective way to complete one? Will ...
Breaking Biology News(10 mins):